Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14478629 | 0.92 | LMNA (0.38) | LMNAALDH1A1USP2THRBCYP1A2 | |
| SCHEMBL12386550 | 0.91 | LMNA (0.39) | LMNAALDH1A1THRB | |
| SCHEMBL14481872 | 0.87 | LMNA (0.38) | LMNAALDH1A1USP2THRBCYP1A2 | |
| SCHEMBL16134391 | 0.87 | USP2 (0.42) | LMNAALDH1A1USP2THRBCYP1A2 | |
| SCHEMBL15519453 | 0.85 | LMNA (0.36) | LMNAALDH1A1USP2THRBTSHR | |
| SCHEMBL13083028 | 0.85 | USP2 (0.41) | LMNAALDH1A1USP2THRBCYP1A2 | |
| SCHEMBL532450 | 0.85 | LMNA (0.48) | LMNAALDH1A1USP2THRBCYP1A2 | |
| SCHEMBL12391763 | 0.85 | USP2 (0.41) | LMNAALDH1A1USP2THRBCYP1A2 | |
| SCHEMBL3334101 | 0.85 | USP2 (0.45) | LMNAALDH1A1USP2THRBKDM4E | |
| SCHEMBL15084202 | 0.85 | LMNA (0.36) | LMNAALDH1A1USP2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2895449-A1 | PROCESS OF STRIPPING A LIQUID MEDIUM | Solvay SA (BE) | 2015-07-22 | — | — | EP | claimed |
| WO-2014040883-A1 | PROCESS OF STRIPPING A LIQUID MEDIUM | SOLVAY SA (BE) | 2014-03-20 | — | — | WO | claimed |
| EP-4349914-A2 | MIXTURES OF BIODEGRADABLE POLYESTERS WITH AT LEAST ONE POLYMER OF NATURAL ORIGIN | Novamont S.p.A. (IT) | 2024-04-10 | — | — | EP | disclosed |
| EP-3640300-B1 | MIXTURES OF BIODEGRADABLE POLYESTERS WITH AT LEAST ONE POLYMER OF NATURAL ORIGIN | NOVAMONT SPA (IT) | 2024-02-21 | — | — | EP | disclosed |
| US-20230331924-A1 | CO-MODIFIED ORGANOPOLYSILOXANE AND USE THEREOF | DOW TORAY CO., LTD. (JP) | 2023-10-19 | — | — | US | disclosed |
| US-10406092-B2 | Method for producing transparent or semi-transparent liquid glycerin-derivative-modified silicone composition | DOW SILICONES CORPORATION (US) | 2019-09-10 | — | — | US | disclosed |
| US-10174170-B2 | Method for producing liquid high-purity polyhydric alcohol derivative-modified silicone or composition thereof | DOW CORNING TORAY CO., LTD. (JP) | 2019-01-08 | — | — | US | disclosed |
| US-20180201780-A1 | IMPROVING THE FLOWABILITY OF THERMOCONDUCTIVE POLYCARBONATE COMPOSITIONS | COVESTRO DEUTSCHLAND AG (DE) | 2018-07-19 | — | — | US | disclosed |
| US-20180201755-A1 | IMPACT-MODIFIED POLYCARBONATE COMPOSITIONS HAVING IMPROVED FLOWABILITY AND A HIGH HEAT DEFLECTION TEMPERATURE | COVESTRO DEUTSCHLAND AG (DE) | 2018-07-19 | — | — | US | disclosed |
| US-20180194926-A1 | BORON NITRIDE-CONTAINING THERMOPLASTIC COMPOSITION | COVESTRO DEUTSCHLAND AG (DE) | 2018-07-12 | — | — | US | disclosed |
| US-20180194925-A1 | BORON NITRIDE HYBRID MATERIAL-CONTAINING THERMOPLASTIC COMPOSITION | COVESTRO DEUTSCHLAND AG (DE) | 2018-07-12 | — | — | US | disclosed |
| WO-2010010463-A2 | TRANSFER METHOD | DANISCO A/S (DK) | 2010-01-28 | — | — | WO | disclosed |
| WO-2009146202-A2 | TRANSKETALIZED COMPOSITIONS, SYNTHESIS, AND APPLICATIONS | SEGETIS, INC. (US) | 2009-12-03 | — | — | WO | disclosed |
| WO-2009121853-A1 | COMPOSITION COMPRISING GLYCEROL, PROCESS FOR OBTAINING SAME AND USE THEREOF IN THE MANUFACTURE OF DICHLOROPROPANOL | Solvay (Société Anonyme) (BE) | 2009-10-08 | — | — | WO | disclosed |
| WO-2009000773-A1 | MANUFACTURE OF DICHLOROPROPANOL | SOLVAY (BE) | 2008-12-31 | — | — | WO | disclosed |
| US-5635588-A | Polymerisation of glycerol using a zeolite catalyst | UNICHEMA CHEMIE B.V. (NL) | 1997-06-03 | — | — | US | disclosed |
| EP-0683800-A1 | POLYMERIZATION OF GLYCEROL USING A ZEOLITE CATALYST. | UNICHEMA CHEMIE BV (NL) | 1995-11-29 | — | — | EP | disclosed |
| WO-1994018259-A1 | POLYMERIZATION OF GLYCEROL USING A ZEOLITE CATALYST | UNICHEMA CHEMIE B.V. (NL) | 1994-08-18 | — | — | WO | disclosed |
| EP-0421928-B1 | Hydroxyphenylcarboxylic acid esters as stabilizers | CIBA GEIGY AG (CH) | 1994-06-15 | — | — | EP | disclosed |
| US-5177246-A | Hydroxphenylcarboxylic acid esters as stabilizers | CIBA-GEIGY CORPORATION (US) | 1993-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10406092-B2 | Method for producing transparent or semi-transparent liquid glycerin-derivative-modified silicone composition | GK, PLIN5, SGMS2 | LMNA 773/4885ALDH1A1 4568/4885USP2 1841/4885 |
| US-20230331924-A1 | CO-MODIFIED ORGANOPOLYSILOXANE AND USE THEREOF | MGLL, LIPA, DAGLB | LMNA 337/4885ALDH1A1 2086/4885USP2 2520/4885 |
| US-10174170-B2 | Method for producing liquid high-purity polyhydric alcohol derivative-modified silicone or composition thereof | SAMM50, SORD, ADH1C | LMNA 200/4885ALDH1A1 945/4885USP2 3274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.